Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $78.20 | Total: $391.00 |
| 1 | 10 | $66.24 | Total: $662.40 |
| 1 | 25 | $56.12 | Total: $1,403.00 |
| 1 | 50 | $47.84 | Total: $2,392.00 |
| 1 | 100 | $41.40 | Total: $4,140.00 |
Overview
Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.
Chemical Properties
| Molecular Formula | C33H33FO6 |
| Molecular Weight | 544.6 |
| CAS Numbers | 161172-51-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCCc1c(OCCCOc2cc(O)c(cc2CC)-c2ccc(F)cc2)cccc1Oc1ccccc1C(O)=O |
Storage and Handling
0C Short Term, -20C Long Term
References
P Marder, et al. Blockade of Human Neutrophil Activation by 2-[2-propyl-3-[3-[2-ethyl-4-[4-fluorophenyl]-5- Hydroxyphenoxy]propoxy]phenoxy]benzoic Acid [LY293111], a Novel Leukotriene B4 Receptor Antagonist. Biochem Pharmacol. 1995 May 26;49[11] 1683-90.